<PAGE> 1
As filed with the Securities and Exchange Commission on December 20, 2000
Registration No. 333-
--------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-----------------
FORM S-8
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
MARTEK BIOSCIENCES CORPORATION
--------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE
--------------------------------------------------------------------------------
(State or other jurisdiction of incorporation or organization)
52-1399362
--------------------------------------------------------------------------------
(I.R.S. employer identification no.)
6480 DOBBIN ROAD, COLUMBIA, MARYLAND 21045
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip code)
MARTEK BIOSCIENCES CORPORATION 1997 STOCK OPTION PLAN, AS AMENDED
-----------------------------------------------------------------
PETER L. BUZY
MARTEK BIOSCIENCES CORPORATION
6480 DOBBIN ROAD
COLUMBIA, MARYLAND 21045
------------------------------------
(Name and address of agent for service)
(410) 740-0081
--------------------------------------------------------------------------------
(Telephone number, including area code, of agent for service)
Copy to:
MICHAEL J. SILVER
HOGAN & HARTSON L.L.P.
111 SOUTH CALVERT STREET
BALTIMORE, MARYLAND 21202
(410) 659-2741
CALCULATION OF REGISTRATION FEE
<TABLE>
<CAPTION>
================================================================================================
Proposed Proposed maximum
maximum offering aggregate Amount of
Title of securities Amount to be price per offering registration
to be registered registered(1) share(1) price(1) fee(1)
------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C>
Stock Options and
Common Stock, par
value $.10 per
share (2) 1,000,000 $14.65625 $14,656,250.00 $3,870.00
================================================================================================
</TABLE>
(1) Pursuant to Rule 457(h)(1), the proposed maximum offering price per
share, proposed maximum aggregate offering price and the amount of the
registration fee are based on the average of the bid and ask price of
$14.65625 per share of Martek Biosciences Corporation common stock on
December 15, 2000 as reported on the NASDAQ National Market.
(2) Includes Series A Preferred Share Purchase Rights attached thereto, for
which no separate fee is payable pursuant to Rule 457(i).
<PAGE> 2
In accordance with Section E of the General Instructions to Form
S-8, the contents of Form S-8, Registration No. 333-27671, filed by Martek
Biosciences Corporation with the Securities and Exchange Commission on May 22,
1997, are incorporated herein by reference for the registration of 1,000,000
additional shares of common stock issuable pursuant to the Martek Biosciences
Corporation 1997 Stock Option Plan, as amended.
<PAGE> 3
EXHIBIT INDEX
<TABLE>
<CAPTION>
Exhibit
Number Description
------ -----------
<S> <C>
5.01 Opinion regarding the legality of the shares of Common Stock being registered
10.01 Amendment to the 1997 Stock Option Plan
23.01 Consent of Ernst & Young LLP
23.02 Consent of Hogan & Hartson L.L.P. (contained in Exhibit 5.01)
24 Power of Attorney (contained on signature page)
</TABLE>
<PAGE> 4
SIGNATURES
Pursuant to the requirements of the Securities Act, the Registrant certifies
that it has reasonable grounds to believe that it meets all of the requirements
for filing on Form S-8 and has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly authorized, in the
County of Howard, Maryland, on December 20, 2000.
Martek Biosciences Corporation
By: /s/ Henry Linsert, Jr.
----------------------------
Henry Linsert, Jr.
Chief Executive Officer
Pursuant to the requirements of the Securities Act of 1933, this Registration
Statement has been signed by the following persons in the capacities and on the
date indicated.
We, the undersigned officers and directors of Martek Biosciences Corporation,
hereby severally and individually constitute and appoint Henry Linsert, Jr.,
Peter L. Buzy and Michael J. Silver, and each of them, the true and lawful
attorneys and agents of each of us to execute in the name, place and stead of
each of us (individually and in any capacity stated below) any and all
amendments to this Registration Statement on Form S-8, and all instruments
necessary or advisable in connection therewith and to file the same with the
Securities and Exchange Commission, each of said attorneys and agents to have
power to act with or without the other and to have full power and authority to
do and perform in the name and on behalf of each of the undersigned every act
whatsoever necessary or advisable to be done in the premises as fully and to all
intents and purposes as any of the undersigned might or could do in person, and
we hereby ratify and confirm our signatures as they may be signed by our said
attorneys and agents and each of them to any and all such amendment and
amendments.
<TABLE>
<S> <C>
Date: December 20, 2000 /s/ Henry Linsert, Jr.
------------------------------------------------
Henry Linsert, Jr.
Chief Executive Officer and Director
(Principal Executive Officer)
Date: December 20, 2000 /s/ Peter L. Buzy
------------------------------------------------
Peter L. Buzy
(Chief Financial and Accounting Officer)
Date: December 20, 2000 /s/ Jules Blake
------------------------------------------------
Jules Blake
Director
Date: December 20, 2000 /s/ Gordon S. Macklin
------------------------------------------------
Gordon S. Macklin
Director
</TABLE>
<PAGE> 5
<TABLE>
<S> <C>
Date: December 20, 2000 /s/ Ann L. Johnson
------------------------------------------------
Ann L. Johnson
Director
Date: December 20, 2000 /s/ Douglas J. MacMaster, Jr.
------------------------------------------------
Douglas J. MacMaster, Jr.
Director
Date: December 20, 2000 /s/ John H. Mahar
------------------------------------------------
John H. Mahar
Director
Date: December 20, 2000 /s/ Sandra Panem
------------------------------------------------
Sandra Panem
Director
Date: December 20, 2000 /s/ Richard J. Radmer
------------------------------------------------
Richard J. Radmer
Director
Date: December 20, 2000 /s/ Eugene H. Rotberg
------------------------------------------------
Eugene H. Rotberg
Director
Date: December 20, 2000 /s/ William D. Smart
------------------------------------------------
William D. Smart
Director
</TABLE>
